Guy Young, MD - Defining the Role of Extended Half-Life Replacement Clotting Factors in the Modern Management of Hemophilia A
Defining the Role of Extended Half-Life Replacement Clotting Factors in the Modern Management of Hemophilia A (Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - March 2, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Guy Young, MD - Defining the Role of Extended Half-Life Replacement Clotting Factors in the Modern Management of Hemophilia A
Defining the Role of Extended Half-Life Replacement Clotting Factors in the Modern Management of Hemophilia A (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - March 2, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Mark T. Reding, MD - Treatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice
Treatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice (Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - November 13, 2018 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Mark T. Reding, MD - Treatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice
Treatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - November 13, 2018 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

State of the Science Inhibitors Workshop: Factor VIII Inhibitors: Generating a National Blueprint for Future Research
The NHLBI State of the Science (SOS) Workshop will be held on the NIH campus in Bethesda, Maryland on May 15 and 16, 2018. The goal of this workshop is to solicit input from all constituencies within the U.S. hemophilia community, as well as international collaborators, into the development of a coordinated and collaborative national blueprint for future, basic, translational, and clinical research focused on factor VIII (FVIII) immunogenicity and FVIII inhibitor prevention and eradication.Air date: 5/16/2018 11:00:00 AM (Source: Videocast - All Events)
Source: Videocast - All Events - May 1, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video

State of the Science Inhibitors Workshop: Factor VIII Inhibitors: Generating a National Blueprint for Future Research
The NHLBI State of the Science (SOS) Workshop will solicit input from all constituencies within the U.S. hemophilia community, as well as international collaborators, into the development of a coordinated and collaborative national blueprint for future, basic, translational, and clinical research focused on factor VIII (FVIII) immunogenicity and FVIII inhibitor prevention and eradication.Air date: 5/15/2018 8:00:00 AM (Source: Videocast - All Events)
Source: Videocast - All Events - April 30, 2018 Category: General Medicine Tags: Upcoming Events Source Type: video

Mark T. Reding, MD - Monitoring Hemostasis in Hemophilia A in an Era of Approved and Emerging Extended Half-Life Factor VIII Therapies: A Visual Guide to Using the Optimal Coagulation Assay and Reagents
Monitoring Hemostasis in Hemophilia A in an Era of Approved and Emerging Extended Half-Life Factor VIII Therapies: A Visual Guide to Using the Optimal Coagulation Assay and Reagents (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - March 16, 2018 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Mark T. Reding, MD - Monitoring Hemostasis in Hemophilia A in an Era of Approved and Emerging Extended Half-Life Factor VIII Therapies: A Visual Guide to Using the Optimal Coagulation Assay and Reagents
Monitoring Hemostasis in Hemophilia A in an Era of Approved and Emerging Extended Half-Life Factor VIII Therapies: A Visual Guide to Using the Optimal Coagulation Assay and Reagents (Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - March 16, 2018 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Guy Young, MD - Assessing Recent Advances in Hemophilia A Management: What Are the Key Learnings From Berlin?
Assessing Recent Advances in Hemophilia A Management: What Are the Key Learnings From Berlin? (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - September 18, 2017 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Guy Young, MD - An Up-to-Date Review of New Data on Modified Replacement Clotting Factors in Hemophilia Management: What Have We Learned in 2016 Thus Far?
An Up-to-Date Review of New Data on Modified Replacement Clotting Factors in Hemophilia Management: What Have We Learned in 2016 Thus Far? (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - September 27, 2016 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Driving CARs to BARs: The Road to Engineered Specific Human T Regulatory Cells
Immunology Interest Group David W. Scott, Ph.D. is Vice Chair for Research in the Department of Medicine at the Uniformed Services School of Health Sciences, Bethesda, MD. An alumnus of Antioch College, he received his M.S. degree from the University of Chicago and Ph.D. from Yale University in 1969. Following a post-doctoral fellowship at Oxford University, he has held tenured faculty positions at Duke University, the University of Rochester, and the University of Maryland Medical School. He assumed his current position in September 2010. Dr. Scott has contributed to over 200 research papers on several subjects on immuno...
Source: Videocast - All Events - June 10, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video

Michael J. Paidas, MD - Contemporary Strategies and Tactics for Augmenting Patient Education and Management Among Individuals with Hemophilia
Contemporary Strategies and Tactics for Augmenting Patient Education and Management Among Individuals with Hemophilia (Source: PeerView CME/CE Video Podcast - Hematology)
Source: PeerView CME/CE Video Podcast - Hematology - June 5, 2015 Category: Hematology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Miguel A. Escobar, MD - Addressing Hemophilia in 2015: How Might Recent Advances Improve Patient Management?
Addressing Hemophilia in 2015: How Might Recent Advances Improve Patient Management? (Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - March 3, 2015 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Miguel A. Escobar, MD - Improving Patient-Practitioner Communication Among Individuals With Hemophilia: An Interactive Discussion
Discussion (Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - December 1, 2014 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Courtney D. Thornburg, MD, MS  - Using Prophylactic Treatment Strategies to Improve Quality of Life and Adherence in Children With Hemophilia
Using Prophylactic Treatment Strategies to Improve Quality of Life and Adherence in Children With Hemophilia (Source: PeerView CME/CE Video Podcast - Hematology)
Source: PeerView CME/CE Video Podcast - Hematology - November 19, 2014 Category: Hematology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Courtney D. Thornburg, MD, MS - Using Prophylactic Treatment Strategies to Improve Quality of Life and Adherence in Children With Hemophilia
Using Prophylactic Treatment Strategies to Improve Quality of Life and Adherence in Children With Hemophilia (Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - November 19, 2014 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Genetic Therapies for Genetic Diseases: Results and Lessons from Recent Successes
Wednesday Afternoon Lecture Series The disease burden represented by genetic disease is high. Genetic diseases account for nearly half of all admissions to children’s hospitals, yet therapeutic options for many of these are limited. The goal of gene therapy is to harness the power of the Human Genome Project to provide better alternatives for those with genetic diseases. After two decades of clinical investigation of gene therapy, the field is able to point to several successes and one licensed product (an AAV vector for lipoprotein lipase deficiency). This lecture will review the vectors that have performed best in...
Source: Videocast - All Events - May 28, 2013 Category: Journals (General) Tags: Upcoming Events Source Type: video